INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Driving Excellence In Aseptic Fill-Finish]( "Driving Excellence In Aseptic Fill-Finish: A Strategic Partnership With Stäubli Robotics")
Driving Excellence In Aseptic Fill-Finish: A Strategic Partnership With Stäubli RoboticsSee how intelligent automation and purpose-built robotics deliver contamination control and operational excellence in demanding sterile manufacturing environments.
-
![GettyImages-1413607446-vial-syringe-liquid-scientist-glove]( "What To Consider When Looking For A CDMO In Drug Substance Utilization")
What To Consider When Looking For A CDMO In Drug Substance UtilizationOptimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.
-
![GettyImages-1316775813 fill finish pharmaceutical bottles]( "Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future")
Fill-Finish Contract Manufacturing: Trends, Challenges, And The FutureSee why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
![GettyImages-1131587509-syringe-vial-injection-inspection]( "Stability Issues Unique To Liquid Injectables And How To Avoid Them")
Stability Issues Unique To Liquid Injectables And How To Avoid ThemLiquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
De-Risking The Transition From Vial To Drug-Device Combination Product7/25/2025
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
-
How To Verify PFS System Performance5/21/2026
PFS system verification shouldn’t force a choice between diverting internal resources or investing in costly external testing. Explore a more efficient path that reduces complexity, cost, and uncertainty in performance validation.
-
Jaw Crimping vs. Rotary Crimping: Enhancing Aseptic Assurance6/12/2025
Beyond a simple mechanical step, crimping is a critical control point. We examine how advanced rotary technology provides superior seal quality, particulate control, and data-driven compliance assurance.
-
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever12/29/2025
As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.
-
AST's Latest Generation GENiSYS® R: Available With Accelerated Delivery7/28/2026
Automated robotic fill-finish and integrated isolator technologies streamline multi-format parenteral manufacturing while ensuring regulatory compliance and maximum yield.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Glass Vials iStock-539331212]( "Low Delamination Propensity Vials")
After conducting extensive research on the chemical performance of the glass vial inner surface and the glass forming process parameters, Stevanato Group added SG LDP Vials to its portfolio. These containers are specifically designed to minimize the formation of surface inhomogeneities.
-
![Vials White Powder]( "Parenteral Filling Technology And Equipment: Powders And Liquids")
The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.
-
![Closed-Pharmaceutical-Restricted-Access-Barrier-System]( "Closed Pharmaceutical Restricted Access Barrier System (RABS) From Franz Ziel")
Closed RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved through a barrier (cRABS housing with gloves) between the operator and the product.
-
Themo Scientific™ Nunc™ Cell Factory™ multi-layer systems are designed for a variety of biological and commercial applications. With a certified Sterility Assurance Level of 10-6 achieved following AAMI/ISO 11137-2-2006 guidelines and Nunclon™ Delta surface treatment, you can be assured of consistent performance from layer to layer and lot to lot. Our cell culture certification includes verification of monolayer formation and cloning efficiency using three cell lines and one primary cell.
-
![Screenshot 2026-01-27 152045]( "Cutting-Edge Software And Gradient Formation Liquid Chromatography Systems")
Efficient purification requires scalable chromatography and advanced automation. Explore how customizable systems and precision software optimize results for peptides, proteins, and oligonucleotides.
